At the end of the review, the US FDA issued a Form 483 with four observations. These relate to enhancements in procedures and are expected to be classified as VAI, or voluntary action indicated.
At the end of the review, the US FDA issued a Form 483 with four observations. These relate to enhancements in procedures and are expected to be classified as VAI, or voluntary action indicated.